Home > M&A deals 2021 > Boehringer Ingelheim GmbH acquires Abexxa Biologics, Inc.
Add-on Acquistion · Life Science · September 2021

Boehringer Ingelheim GmbH acquires Abexxa Biologics, Inc.

On September 21, 2021, Boehringer Ingelheim GmbH acquired Abexxa Biologics, Inc., a life science company in Texas, United States.

Deal at a glance

AnnouncedSeptember 21, 2021 TypeAdd-on Acquistion TargetAbexxa Biologics, Inc. Buyer Boehringer Ingelheim GmbH SectorLife Science LocationTexas, United States ValueNot disclosed

Target company

Abexxa Biologics, Inc.
Texas, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Boehringer Ingelheim GmbH
Company · 8 deals on record
  • 4th transaction in life science
  • 1st transaction in United States
8deals, all time
4in this sector
2021latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Abexxa Biologics, Inc.?Boehringer Ingelheim GmbH acquired Abexxa Biologics, Inc. on September 21, 2021.

What type of deal was it?It was a add-on acquistion in the life science sector in 2021.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).